All In Biotech

Free tool

FAERS Monitor: Zetia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021445 or its brand name (Zetia, Ezetimibe). Reports on generic versions are filed under their own applications.

Reports

76,879

Serious

50,222

65% of reports

Hospitalization

22,578

Death reported

4,407

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue5,145
  • myalgia4,604
  • nausea4,572
  • diarrhoea4,115
  • drug ineffective3,829
  • dizziness3,694
  • dyspnoea3,566
  • headache3,507
  • arthralgia3,164
  • asthenia3,019
  • pain2,984
  • fall2,509
  • pain in extremity2,503
  • off label use2,492
  • vomiting2,470

Reports by year received

View as table
YearReports
20042,321
20052,248
20061,524
20071,599
20081,797
20091,831
20102,315
20112,115
20122,269
20131,897
20142,064
20153,133
20163,057
20172,994
20183,683
20194,009
20204,037
20213,990
20224,656
20235,346
20246,185
20257,349
20266,459

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,977,280 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myalgiaSignal4,6047.67.425,819
pain in extremitySignal2,5032.32.21,921
astheniaSignal3,0192.22.12,010
arthralgiaSignal3,1642.12.01,820
fallSignal2,5092.12.01,399
dizzinessSignal3,6942.02.01,973
fatigue5,1451.81.81,935
diarrhoea4,1151.71.71,352
dyspnoea3,5661.71.71,116
nausea4,5721.61.51,016
headache3,5071.51.5666
vomiting2,4701.41.4337
pain2,9841.31.3251
drug ineffective3,8290.80.8217
off label use2,4920.80.7164

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.